(Total Views: 96)
Posted On: 09/13/2022 1:53:11 PM
Post# of 21237

$NBIO trading nearly 40% of its 10-day average volume as we approach the last 2 hours of the day... But UP almost 6% on today's News.
Nascent Biotech Completes Fourth Cohort in Phase 1 Human Trial for Primary and Metastatic Brain Cancer https://finance.yahoo.com/news/nascent-biotec...00517.html
Nascent Biotech Completes Fourth Cohort in Phase 1 Human Trial for Primary and Metastatic Brain Cancer https://finance.yahoo.com/news/nascent-biotec...00517.html

